Meet Federico Mingozzi, PhD: ASGCT Volunteer Rockstar

ASGCT is a volunteer-led organization, and it could not effectively pursue its mission and strategic vision without the commitment of its volunteers. The Society does so through 32 standing, scientific, and board committees supported by more than 400 member volunteers. We recognize our committee leaders for their time, commitment, and expertise, and appreciate their willingness to help ASGCT advance the field of gene and cell therapy in a unique and meaningful way. 

*****

Federico Mingozzi, PhD, has more than 25 years of experience in gene therapy, immunology, biochemistry, and molecular biology in both industry and academic settings. Currently, he is the Chief Science & Technology Officer at Spark Therapeutics, a member of the Roche group, and has previously held leadership positions at the Children’s Hospital of Philadelphia (CHOP), the French National Institute of Health and Medical Research (INSERM), and Genethon.

Dr. Mingozzi has received several awards and has contributed to the field with scientific publications describing seminal findings in the field of AAV gene therapy. He received his bachelor’s degree in biology and his PhD in biochemistry and molecular biology from the University of Ferrara in Italy, and his MBA from Drexel University. 

Dr. Mingozzi has been a member of several committees. He is the current chair of the Immune Responses to Gene and Cell Therapy committee and a member of the Global Outreach committee. He is responsible for directing the committee as they develop programming for the Annual Meeting, Insight Series, and other Society events. 

ASGCT thanks Dr. Mingozzi for his service on an ASGCT scientific committee. Our members serve as subject matter experts for Society-led projects, including Annual Meeting programming. and we could not do the work we do without them. 

For questions on ASGCT committees or volunteer process, please contact Dani Gale (dgale@asgct.org)

Related Articles